定量CT身体组分分析在2型糖尿病中的 研究进展
Research Progress of Quantitative CT Body Composition Analysis in Type 2 Diabetes Mellitus
DOI: 10.12677/acm.2026.1672508, PDF,   
作者: 杨宏艳：承德医学院研究生学院，河北 承德；赵 巍*：邢台市人民医院CT、MR科，河北 邢台
关键词: 2型糖尿病；定量CT；身体组分；T2DM； QCT； Body Composition
摘要: 2型糖尿病(Type 2 diabetes mellitus, T2DM)已成为全球性重大公共卫生挑战。体重指数(Body mass index, BMI)、双能X线吸收法(Dual-energy X-ray absorptiometry, DXA)及腰围等传统身体组分评估方法无法实现对身体组分精准定量分析。定量CT(Quantitative computed tomography, QCT)以临床CT扫描为基础，经QCT体模校准和专业软件分析，可精准测量身体组分。本文综述QCT在T2DM患者身体组分分析中的研究进展，重点阐述QCT技术的应用、身体组分与T2DM及其并发症发生发展的关联、以及QCT在评估不同治疗措施效果中的应用价值，旨在为T2DM的早期筛查与个体化诊疗提供参考。
Abstract: Type 2 diabetes mellitus (T2DM) has emerged as a major global public health challenge. Traditional body composition assessment methods, such as body mass index (BMI), dual-energy X-ray absorptiometry (DXA), and waist circumference, cannot provide precise quantitative analysis of body composition. Quantitative computed tomography (QCT), which is based on clinical CT scans and calibrated using a QCT phantom and specialized software, enables accurate measurement of body composition. This review summarizes the research progress of QCT in body composition analysis of patients with T2DM. It focuses on the application of QCT technology, the association between body composition and the development and progression of T2DM and its complications, and the value of QCT in evaluating the efficacy of different therapeutic interventions. This review aims to provide a reference for early screening and individualized diagnosis and treatment of T2DM.
文章引用：杨宏艳, 赵巍. 定量CT身体组分分析在2型糖尿病中的 研究进展[J]. 临床医学进展, 2026, 16(7): 149-156. https://doi.org/10.12677/acm.2026.1672508

参考文献

[1] Genitsaridi, I., Salpea, P., Salim, A., Sajjadi, S.F., Tomic, D., James, S., et al. (2026) 11th Edition of the IDF Diabetes Atlas: Global, Regional, and National Diabetes Prevalence Estimates for 2024 and Projections for 2050. The Lancet Diabetes & Endocrinology, 14, 149-156. [Google Scholar] [CrossRef] 
[2] 黄婧荷, 郭立新. 内脏脂肪与2型糖尿病相关性的研究进展[J]. 中华糖尿病杂志, 2024, 16(10): 1147-1151.
[3] Cann, C.E. and Genant, H.K. (1980) Precise Measurement of Vertebral Mineral Content Using Computed Tomography. Journal of Computer Assisted Tomography, 4, 493-500. [Google Scholar] [CrossRef] [PubMed]
[4] 程晓光, 王亮, 曾强, 等. 中国定量CT(QCT)骨质疏松症诊断指南(2018) [J]. 中国骨质疏松杂志, 2019, 25(6): 733-737.
[5] 中华医学会健康管理学分会, 国家骨科医学中心(首都医科大学附属北京积水潭医院), 国家级放射影像专业质控中心, 等. 定量CT在健康管理中的应用指南(2024) [J]. 中华健康管理学杂志, 2024, 18(9): 645-654.
[6] 徐黎, 过哲, 张晨鑫, 等. 定量CT与MR mDixon-quant测量肝脏脂肪含量的相关性研究[J]. 放射学实践, 2017, 32(5): 456-461.
[7] Damilakis, J., Adams, J.E., Guglielmi, G. and Link, T.M. (2010) Radiation Exposure in X-Ray-Based Imaging Techniques Used in Osteoporosis. European Radiology, 20, 2707-2714. [Google Scholar] [CrossRef] [PubMed]
[8] Wu, Y., Jiang, Y., Han, X., Wang, M. and Gao, J. (2018) Application of Low-Tube Current with Iterative Model Reconstruction on Philips Brilliance iCT Elite FHD in the Accuracy of Spinal QCT Using a European Spine Phantom. Quantitative Imaging in Medicine and Surgery, 8, 32-38. [Google Scholar] [CrossRef] [PubMed]
[9] 杨雁, 陈颖, 张惠杰, 等. 糖尿病患者体重管理专家共识(2024版) [J]. 中华糖尿病杂志, 2024, 16(9): 959-971.
[10] Bai, J., Gao, C., Li, X., Pan, H., Wang, S., Shi, Z., et al. (2023) Correlation Analysis of the Abdominal Visceral Fat Area with the Structure and Function of the Heart and Liver in Obesity: A Prospective Magnetic Resonance Imaging Study. Cardiovascular Diabetology, 22, Article No. 206. [Google Scholar] [CrossRef] [PubMed]
[11] 李鑫, 周阳, 邹智, 等. 基于定量CT分析正常体质量指数人群内脏脂肪面积与甘油三酯-葡萄糖指数的相关性[J]. 中国医学影像技术, 2025, 41(1): 104-108.
[12] Zhang, B., Wu, Z., Jiang, C., Li, N., An, X., Tian, L., et al. (2025) Quantitative CT Assessment of Skeletal Muscle and Abdominal Fat Distribution: Predictive Value for Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity, 18, 4153-4163. [Google Scholar] [CrossRef] 
[13] 罗樱樱, 纪立农. 代谢性疾病的管理: 关注机体异位脂肪沉积[J]. 中华内分泌代谢杂志, 2024, 40(4): 345-349.
[14] 毛立芸, 楼青青, 尚婷, 等. 定量CT在2型糖尿病患者肝脏脂肪含量定量分析中的应用价值[J]. 广西医学, 2022, 44(24): 2852-2856.
[15] 杨梦, 任帅, 李源, 等. 定量CT与MRI测量2型糖尿病患者胰腺脂肪含量的一致性研究[J]. 中国中西医结合影像学杂志, 2025, 23(1): 74-79.
[16] 梁玉龙, 郭翔宇, 陈涛, 等. 基于定量CT分析肝脂肪变性与中医体质及代谢指标的相关性[J]. 中国CT和MRI杂志, 2023, 21(7): 112-114.
[17] 高爱军, 白煜, 牛贺珍, 等. 定量CT诊断胰腺脂肪沉积及与2型糖尿病的相关性分析[J]. 中国CT和MRI杂志, 2023, 21(6): 116-118.
[18] Yang, M., Chen, J., Yue, J., He, S., Fu, J., Qi, Y., et al. (2023) Liver Fat Is Superior to Visceral and Pancreatic Fat as a Risk Biomarker of Impaired Glucose Regulation in Overweight/Obese Subjects. Diabetes, Obesity and Metabolism, 25, 716-725. [Google Scholar] [CrossRef] [PubMed]
[19] 王雨竹, 郁万江, 李烁. 定量CT测量超重/肥胖人群胰腺脂肪含量及其与2型糖尿病的相关性[J]. 中国医学影像学杂志, 2022, 30(6): 620-624.
[20] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[21] Liu, Y., Zhao, D., Chai, S. and Zhang, X. (2024) Association of Visceral Adipose Tissue with Albuminuria and Interaction between Visceral Adiposity and Diabetes on Albuminuria. Acta Diabetologica, 61, 909-916. [Google Scholar] [CrossRef] [PubMed]
[22] 黄佳琪, 徐莹, 田园, 等. 内脏脂肪面积对早期糖尿病肾病影响的临床观察[J]. 临床和实验医学杂志, 2023, 22(17): 1843-1846.
[23] 李庆祝, 张倩, 何春玲, 等. 基于定量CT分析2型糖尿病患者腹部脂肪含量与骨密度相关性研究[J]. 皖南医学院学报, 2024, 43(1): 52-55.
[24] Ma, X. and Zhang, X. (2025) Research Progress of Diabetic Osteoporosis: A Comprehensive Review. Frontiers in Endocrinology, 16, Article 1595228. [Google Scholar] [CrossRef] 
[25] Zhang, X., Xu, D., Zhang, R., Wang, H. and Yang, G. (2025) Interaction between Diabetes and Osteoporosis: Imbalance between Inflammation and Bone Remodeling. Osteoporosis International, 36, 2401-2409. [Google Scholar] [CrossRef] 
[26] 夏宁, 廖冬发, 李相位, 等. 定量CT在骨质疏松诊疗中的应用进展[J]. 中国医学科学院学报, 2025, 47(1): 118-123.
[27] Yang, J., Zeng, Y. and Yu, W. (2025) Criteria for Osteoporosis Diagnosis: A Systematic Review and Meta-Analysis of Osteoporosis Diagnostic Studies with DXA and QCT. eClinicalMedicine, 83, Article ID: 103244. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, F., Wang, Q., Wu, L., Liu, J., Xiong, M., Chen, J., et al. (2025) Clinical Value of Dual Detector Spectral CT in Fracture Risk Prediction in Patients with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study. Medicine, 104, e44347. [Google Scholar] [CrossRef] 
[29] Fan, Y., Wu, H., Lau, E.S.H., Shi, M., Fan, B., Yang, A., et al. (2026) Associations of General Adiposity, Abdominal Adiposity, and Their Changes with Fracture Risk in Chinese Individuals with Type 2 Diabetes. Diabetes Care, 49, 1246-1257. [Google Scholar] [CrossRef] 
[30] Sun, M., Chen, W., Lin, Z., Ye, E., Peng, M., Chen, L., et al. (2026) Visceral Fat Area as a Predictor for Macrovascular Complications in Patients with Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 17, Article 1636998. [Google Scholar] [CrossRef] 
[31] Wu, Q., He, Y., Li, P., Gu, S., Song, R., Zhang, D., et al. (2025) Exploring the Link between Visceral Fat and Cardiovascular Disease in Type 2 Diabetes: Evidence from CT Measurements. Frontiers in Endocrinology, 16, Article 1635282. [Google Scholar] [CrossRef] 
[32] 谢玉海, 李小虎, 侯唯姝, 等. 基于QCT测量的腹腔内脏脂肪面积与II型糖尿病患者冠状动脉钙化的相关性[J]. 临床放射学杂志, 2025, 44(12): 2303-2309.
[33] Antonio-Villa, N.E., Juárez-Rojas, J.G., Posadas-Sánchez, R., Reyes-Barrera, J. and Medina-Urrutia, A. (2023) Visceral Adipose Tissue Is an Independent Predictor and Mediator of the Progression of Coronary Calcification: A Prospective Sub-Analysis of the GEA Study. Cardiovascular Diabetology, 22, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[34] 盛鲁光, 刘丹丹, 刘维斌, 等. 短期饮食干预对肥胖合并糖代谢异常患者的影响研究[J]. 中国全科医学, 2026, 29(3): 373-379.
[35] Tang, F., Wang, W., Wang, Y., Lee, Y. and Lou, Q. (2024) Moderate Resistance Training Reduces Intermuscular Adipose Tissue and Risk Factors of Atherosclerotic Cardiovascular Disease for Elderly Patients with Type 2 Diabetes. Diabetes, Obesity and Metabolism, 26, 3418-3428. [Google Scholar] [CrossRef] [PubMed]
[36] Gao, X., Duan, J., Cui, B., Li, P., Su, Z., Li, W., et al. (2025) Impact of Sleeve Gastrectomy on Ectopic Fat Deposition and Skeletal Muscle Composition across Glucose Metabolic States. Obesity Surgery, 35, 2689-2697. [Google Scholar] [CrossRef] [PubMed]
[37] Yuan, X., Zhu, W., Hao, Z., Li, J., Zhang, T., Li, W., et al. (2025) Characteristics of Changes in Bone Mineral Density and Body Composition in Obesity Patients after Metabolic and Bariatric Surgery: A Prospective Cohort Study. Diabetes, Obesity and Metabolism, 27, 4968-4977. [Google Scholar] [CrossRef] [PubMed]
[38] Qiao, X., Wang, W., Cao, J., Guo, L. and Pan, Q. (2026) Efficacy of Weight‐Lowering Agents on Fat Distribution: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials. Obesity Reviews, 27, e70100. [Google Scholar] [CrossRef] 
[39] Shen, Y., Shi, Q., Zou, X., Meng, W., Tian, H., Du, L., et al. (2024) Time‐Dependent Risk of Fracture in Adults with Type 2 Diabetes Receiving Anti‐Diabetic Drug: A One‐Stage Network Meta‐Analysis. Diabetes/Metabolism Research and Reviews, 40, e3780. [Google Scholar] [CrossRef] [PubMed]
[40] Kupai, K., Kang, H.L., Pósa, A., Csonka, Á., Várkonyi, T. and Valkusz, Z. (2024) Bone Loss in Diabetes Mellitus: Diaporosis. International Journal of Molecular Sciences, 25, Article 7269. [Google Scholar] [CrossRef] [PubMed]
[41] Wang, X., Wu, N., Sun, C., Jin, D. and Lu, H. (2023) Effects of SGLT-2 Inhibitors on Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetology & Metabolic Syndrome, 15, e38444. [Google Scholar] [CrossRef] [PubMed]
[42] Malandris, K., Papandreou, S., Avgerinos, I., Karagiannis, T., Paschos, P., Michailidis, T., et al. (2023) Comparative Efficacy of Glucose-Lowering Drugs on Liver Steatosis as Assessed by Means of Magnetic Resonance Imaging in Patients with Type 2 Diabetes Mellitus: Systematic Review and Network Meta-analysis. Hormones, 22, 655-664. [Google Scholar] [CrossRef] [PubMed]
[43] Kakegawa, T., Sugimoto, K., Saito, K., Yunaiyama, D., Araki, Y., Wada, T., et al. (2024) Favorable Liver and Skeletal Muscle Changes in Patients with MASLD and T2DM Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Prospective Cohort Study. Medicine, 103, e38444. [Google Scholar] [CrossRef] [PubMed]

为你推荐